Neurocrine Biosciences



Ebit تغيير تاريخ
AbbVie USD 5.24B 1.5B 2024-12
Acadia Pharmaceuticals USD 6.99M 24.66M 2024-12
Agios Pharmaceuticals USD -125037000 22.23M 2024-12
ALKERMES USD 162.69M 46.46M 2024-12
Alnylam Pharmaceuticals USD -105159000 28.25M 2024-12
Amgen USD 4.03B 11M 2024-12
Biogen USD 644.1M 100.9M 2024-12
BioMarin Pharmaceutical USD 161.41M 47.51M 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
Dynavax Technologies USD -1632000 11.71M 2024-12
Exelixis USD 163.46M 27.38M 2024-12
Gilead Sciences USD 3.11B 144M 2024-12
Halozyme Therapeutics USD 182.75M 19.56M 2024-12
Incyte USD 376.26M 121.03M 2024-12
Intra Cellular Therapies USD -29197000 9.65M 2024-12
Ionis Pharmaceuticals USD -110000000 38M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Prothena USD -64897000 1.62M 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Repligen USD 25M 1.9M 2024-12
Sarepta Therapeutics USD 161.68M 139.48M 2024-12
Teva Pharmaceutical Industries USD 1.17B 100M 2024-12
Ultragenyx Pharmaceutical USD -122278000 9.71M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12



Neurocrine Biosciences - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Mar 2025.